European Launch Imminent After CHMP OK for Lixisenatide
By Cormac Sheridan
Wednesday, November 21, 2012
Zealand Pharmaceuticals A/S is set to join what is still an all too select club of European biotechnology firms with a product approval under their belts.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.